← Companies|Ache Laboratorios
Ac

Ache Laboratorios

Guarulhos BRFounded 19665,500 employees
Private CappharmaPrivateGICardiology
Platform: GI Cardio
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ACH-2340ACH-2340Phase 33ADCCDK4/6JAK1/2iMesoPNH
RimazanubrutinibACH-5762NDA/BLA1ASOWRNMeniniCSU
TixalucimabACH-5621Approved1MultispecificAHRALKiMG
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)
2025-03-15
Tixalucimab Ph3 Readout
MG
Past
2027-07-13
Rimazanubrutinib Ph3 Readout
CSU
Ph3 Readout
2028-05-05
ACH-2340 Ph3 Readout
FSGS
Ph3 Readout
2029-06-05
ACH-2340 Ph3 Readout
Meso
Ph3 Readout